Brain Tumours

Conclusions

• Cure is probably restricted to younger patients => cure might even be achieved when the tumor recurs • Standard of care is only poorly defined => further trials are urgently needed • Whenever possible, HD-MTX should be administered • Avoid WBRT when possible • Open questions: • Role for rituximab? • Optimal treatment for elderly/frail patients?